Graham Michael Wynne

Person

Oxford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Quinoline compounds
- Patent number 9,822,078
- Issue date Nov 21, 2017
- Oxford University Innovation Limited
- David Vaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibacterial compounds
- Patent number 9,763,925
- Issue date Sep 19, 2017
- Summit Therapeutics PLC
- Francis Xavier Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibacterial compounds
- Patent number 9,314,456
- Issue date Apr 19, 2016
- Summit Therapeutics PLC
- Francis Xavier Wilson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,980,927
- Issue date Mar 17, 2015
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibacterial compounds
- Patent number 8,975,416
- Issue date Mar 10, 2015
- Summit Corporation PLC
- Paul James Davis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,563,536
- Issue date Oct 22, 2013
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,536,158
- Issue date Sep 17, 2013
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of Duchenne muscular dystrophy
- Patent number 8,518,980
- Issue date Aug 27, 2013
- Summit Corporation PLC
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Drug combinations for the treatment of duchenne muscular dystrophy
- Patent number 8,501,713
- Issue date Aug 6, 2013
- Summit Corporation PLC
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,268,878
- Issue date Sep 18, 2012
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 8,168,673
- Issue date May 1, 2012
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of duchenne muscular dystrophy
- Patent number 8,138,351
- Issue date Mar 20, 2012
- Summit Corporation PLC
- Graham Michael Wynne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Integrin antagonists useful as anticancer agents
- Patent number 8,003,806
- Issue date Aug 23, 2011
- OSI Pharmaceuticals, LLC
- Jason Bloxham
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,999,119
- Issue date Aug 16, 2011
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,919,512
- Issue date Apr 5, 2011
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds having CRTH2 antagonist activity
- Patent number 7,750,027
- Issue date Jul 6, 2010
- Oxagen Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
(2-carboxamido)(3-Amino) thiophene compounds
- Patent number 7,696,225
- Issue date Apr 13, 2010
- OSI Pharmaceuticals, Inc.
- Jason Bloxham
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-substituted benzimidazolyl c-Kit inhibitors
- Patent number 7,521,448
- Issue date Apr 21, 2009
- OSI Pharmaceuticals, Inc.
- Joshua Bolger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2-carboxamido)(3-amino)thiophene compounds
- Patent number 6,949,563
- Issue date Sep 27, 2005
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SQUALENE COMPOUNDS AS MODULATORS OF LDL-RECEPTOR EXPRESSION
- Publication number 20170260126
- Publication date Sep 14, 2017
- Oxford University Innovation Limited
- Graham Michael Wynne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
QUINOLINE COMPOUNDS
- Publication number 20170008849
- Publication date Jan 12, 2017
- Oxford University Innovation Limited
- David Vaux
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBACTERIAL COMPOUNDS
- Publication number 20160184283
- Publication date Jun 30, 2016
- Summit Therapeutics PLC
- Francis Xavier WILSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20150246030
- Publication date Sep 3, 2015
- Atopix Therapeutics Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBACTERIAL COMPOUNDS
- Publication number 20150150861
- Publication date Jun 4, 2015
- SUMMIT CORPORATION PLC
- Francis Xavier WILSON
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cannabinoid-2-Receptor Agonists
- Publication number 20140378451
- Publication date Dec 25, 2014
- Ivy Christou
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20140039012
- Publication date Feb 6, 2014
- Atopix Therapeutics Limited
- Richard Edward Armer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
- Publication number 20140018320
- Publication date Jan 16, 2014
- SUMMIT CORPORATION PLC
- GRAHAM MICHAEL WYNNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
- Publication number 20140011782
- Publication date Jan 9, 2014
- Graham Michael WYNNE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBACTERIAL COMPOUNDS
- Publication number 20120020950
- Publication date Jan 26, 2012
- SUMMIT CORPORATION PLC
- Paul James Davis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110268693
- Publication date Nov 3, 2011
- Oxagen Limited
- Richard Edward ARMER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DIS...
- Publication number 20110237538
- Publication date Sep 29, 2011
- SUMMIT CORPORATION PLC
- Olivier De Moor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Drug Combinations for the Treatment of Duchenne Muscular Dystrophy
- Publication number 20110195932
- Publication date Aug 11, 2011
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS
- Publication number 20110195929
- Publication date Aug 11, 2011
- SUMMIT CORPORATION PLC
- Olivier De Moor
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110142855
- Publication date Jun 16, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20110123547
- Publication date May 26, 2011
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF COMPOUNDS FOR PREPARING ANTI-TUBERCULOSIS AGENTS
- Publication number 20100317607
- Publication date Dec 16, 2010
- INFECTIOUS DISEASE RESEARCH INSTITUTE
- Graham Michael Wynne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20100305120
- Publication date Dec 2, 2010
- BIOMARIN IGA LIMITED
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100266535
- Publication date Oct 21, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
- Publication number 20100267961
- Publication date Oct 21, 2010
- BIOMARIN IGA. LIMITED CORPORATION
- Graham Wynne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Drug Combinations for the Treatment of Duchenne Muscular Dystrophy
- Publication number 20100168072
- Publication date Jul 1, 2010
- BIOMARIN IGA LIMITED
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100063103
- Publication date Mar 11, 2010
- Oxagen Limited
- Richard Edward ARMER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
- Publication number 20100048660
- Publication date Feb 25, 2010
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100035956
- Publication date Feb 11, 2010
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20100022613
- Publication date Jan 28, 2010
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20090192195
- Publication date Jul 30, 2009
- Oxagen Limited
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Compounds Having CRTH2 Antagonist Activity
- Publication number 20090186923
- Publication date Jul 23, 2009
- Richard Edward Armer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY
- Publication number 20090075938
- Publication date Mar 19, 2009
- Graham Michael Wynne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-substituted benzimidazolyl c-Kit inhibitors
- Publication number 20060189629
- Publication date Aug 24, 2006
- Joshua Bolger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Integrin antagonists useful as anticancer agents
- Publication number 20060116383
- Publication date Jun 1, 2006
- Jason Bloxham
- C07 - ORGANIC CHEMISTRY

Graham Michael Wynne

Person

Patents Grantslast 30 patents

Quinoline compounds

Antibacterial compounds

Antibacterial compounds

Compounds having CRTH2 antagonist activity

Antibacterial compounds

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Treatment of Duchenne muscular dystrophy

Drug combinations for the treatment of duchenne muscular dystrophy

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Treatment of duchenne muscular dystrophy

Integrin antagonists useful as anticancer agents

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

Compounds having CRTH2 antagonist activity

(2-carboxamido)(3-Amino) thiophene compounds

N-substituted benzimidazolyl c-Kit inhibitors

(2-carboxamido)(3-amino)thiophene compounds

Patents Applicationslast 30 patents

SQUALENE COMPOUNDS AS MODULATORS OF LDL-RECEPTOR EXPRESSION

QUINOLINE COMPOUNDS

ANTIBACTERIAL COMPOUNDS

Compounds Having CRTH2 Antagonist Activity

ANTIBACTERIAL COMPOUNDS

Cannabinoid-2-Receptor Agonists

Compounds Having CRTH2 Antagonist Activity

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

DRUG COMBINATIONS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

ANTIBACTERIAL COMPOUNDS

Compounds Having CRTH2 Antagonist Activity

TREATMENT OF LYSOSOMAL STORAGE DISORDERS AND OTHER PROTEOSTATIC DIS...

Drug Combinations for the Treatment of Duchenne Muscular Dystrophy

COMPOUNDS FOR THE TREATMENT OF FLAVIVIRAL INFECTIONS

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

USE OF COMPOUNDS FOR PREPARING ANTI-TUBERCULOSIS AGENTS

COMPOUNDS FOR TREATING MUSCULAR DYSTROPHY

Compounds Having CRTH2 Antagonist Activity

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Drug Combinations for the Treatment of Duchenne Muscular Dystrophy

Compounds Having CRTH2 Antagonist Activity

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

Compounds Having CRTH2 Antagonist Activity

TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

N-substituted benzimidazolyl c-Kit inhibitors

Integrin antagonists useful as anticancer agents